Lindsay E. Nicolle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lindsay E. Nicolle has a total of 275 co-authors. Here are the top co-authors by number of shared publications:
Mary Cheang
From the Departments of *Medical Microbiology, †Community Health Sciences, and ††Internal Medicine, Health Sciences Centre, University of Manitoba, Winnipeg, Manitoba, Canada‡Hamilton Regional Laboratory Medicine, **St. Joseph's Health Care System Research Network McMaster University, Hamilton, Ontario, Canada§Department of Microbiology∥Geriatric Medicine, University of Toronto, Ontario, Canada#Department of Internal Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
2 shared publicationsRinaldo Bellomo
2 shared publications- Shelly A. McNeil
Canadian Center for Vaccinology, IWK Health, Nova Scotia Health, Dalhousie University , Halifax, Nova Scotia
2 shared publications A. Simor
Univ Toronto, Dept Microbiol, Toronto, ON, Canada
1 shared publicationAdam Romanovsky
1 shared publication- Ajay K. Israni
Renal-Electrolyte & Hypertension Division, Department of Medicine, University of Pennsylvania School of Medicine, Pennsylvania, USA
1 shared publication
Latest Publications
- 13 June 2019
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 70 (5) , 988-989
Reply to Coussement et al
Lindsay E Nicolle, Reed Siemieniuk; Reply to Coussement, et al, Clinical Infectious Diseases, , ciz508, https://doi.org/10.1093/cid/ciz508
- 13 June 2019
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 70 (5) , 988-989
Reply to Coussement et al
Lindsay E Nicolle, Reed Siemieniuk; Reply to Coussement, et al, Clinical Infectious Diseases, , ciz508, https://doi.org/10.1093/cid/ciz508
- 1 August 2016
- Published by Elsevier in Clinics in Geriatric Medicine
- Vol. 32 (3) , 523-538
Urinary Tract Infections in the Older Adult
- 1 August 2016
- Published by Elsevier in Clinics in Geriatric Medicine
- Vol. 32 (3) , 523-538
Urinary Tract Infections in the Older Adult
- Open Access
The Paradigm Shift to Non-Treatment of Asymptomatic Bacteriuria
Asymptomatic bacteriuria, also called asymptomatic urinary infection, is a common finding in healthy women, and in women and men with abnormalities of the genitourinary tract. The characterization and introduction of the quantitative urine culture in the 1950s first allowed the reliable recognition of asymptomatic bacteriuria. The observations that a substantial proportion of patients with chronic pyelonephritis at autopsy had no history of symptomatic urinary infection, and the high frequency of pyelonephritis observed in pregnant women with untreated asymptomatic bacteriuria, supported a conclusion that asymptomatic bacteriuria was harmful. Subsequent screening and long term follow-up programs for asymptomatic bacteriuria in schoolgirls and women reported an increased frequency of symptomatic urinary tract infection for subjects with asymptomatic bacteriuria, but no increased morbidity from renal failure or hypertension, or increased mortality. Treatment of asymptomatic bacteriuria did not decrease the frequency of symptomatic infection. Prospective, randomized, comparative trials enrolling premenopausal women, children, elderly populations, patients with long term catheters, and diabetic patients consistently report no benefits with antimicrobial treatment of asymptomatic bacteriuria, and some evidence of harm. Several studies have also reported that antimicrobial treatment of asymptomatic bacteriuria increases the short term risk of pyelonephritis. Current investigations are exploring the potential therapeutic intervention of establishing asymptomatic bacteriuria with an avirulent Escherichia coli strain to prevent symptomatic urinary tract infection for selected patients.
Open AccessThe Paradigm Shift to Non-Treatment of Asymptomatic Bacteriuria
Asymptomatic bacteriuria, also called asymptomatic urinary infection, is a common finding in healthy women, and in women and men with abnormalities of the genitourinary tract. The characterization and introduction of the quantitative urine culture in the 1950s first allowed the reliable recognition of asymptomatic bacteriuria. The observations that a substantial proportion of patients with chronic pyelonephritis at autopsy had no history of symptomatic urinary infection, and the high frequency of pyelonephritis observed in pregnant women with untreated asymptomatic bacteriuria, supported a conclusion that asymptomatic bacteriuria was harmful. Subsequent screening and long term follow-up programs for asymptomatic bacteriuria in schoolgirls and women reported an increased frequency of symptomatic urinary tract infection for subjects with asymptomatic bacteriuria, but no increased morbidity from renal failure or hypertension, or increased mortality. Treatment of asymptomatic bacteriuria did not decrease the frequency of symptomatic infection. Prospective, randomized, comparative trials enrolling premenopausal women, children, elderly populations, patients with long term catheters, and diabetic patients consistently report no benefits with antimicrobial treatment of asymptomatic bacteriuria, and some evidence of harm. Several studies have also reported that antimicrobial treatment of asymptomatic bacteriuria increases the short term risk of pyelonephritis. Current investigations are exploring the potential therapeutic intervention of establishing asymptomatic bacteriuria with an avirulent Escherichia coli strain to prevent symptomatic urinary tract infection for selected patients.
- 19 February 2016
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 37 (3) , 334-336
Catheter Matters
- 19 February 2016
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 37 (3) , 334-336
Catheter Matters
- 4 February 2016
- Published by Springer Nature in Current Geriatrics Reports
- Vol. 5 (1) , 1-8
Asymptomatic Bacteriuria in Older Adults
- 4 February 2016
- Published by Springer Nature in Current Geriatrics Reports
- Vol. 5 (1) , 1-8
Asymptomatic Bacteriuria in Older Adults
- 1 November 2015
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 15 (11) , 1252-1254
Management of asymptomatic bacteriuria in pregnant women
- 1 November 2015
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 15 (11) , 1252-1254
Management of asymptomatic bacteriuria in pregnant women
- 4 September 2015
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 3 (5)
Asymptomatic Bacteriuria and Bacterial Interference
Asymptomatic bacteriuria is very common. In healthy women, asymptomatic bacteriuria increases with age, from Escherichia coli is the most frequent organism isolated, but a wide variety of other organisms may occur. Bacteriuria may be transient or persist for a prolonged period. Pregnant women with asymptomatic bacteriuria identified in early pregnancy and who are untreated have a risk of pyelonephritis later in pregnancy of 20% to 30%. Bacteremia is frequent in bacteriuric subjects following mucosal trauma with bleeding, with 5% to 10% of patients developing severe sepsis or septic shock. These two groups with clear evidence of negative outcomes should be screened for bacteriuria and appropriately treated. Asymptomatic bacteriuria in other populations is benign and screening and treatment are not indicated. Antimicrobial treatment has no benefits but is associated with negative outcomes including reinfection with antimicrobial resistant organisms and a short-term increased frequency of symptomatic infection post-treatment. The observation of increased symptomatic infection post-treatment, however, has led to active investigation of bacterial interference as a strategy to prevent symptomatic episodes in selected high risk patients.
- 4 September 2015
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 3 (5)
Asymptomatic Bacteriuria and Bacterial Interference
Asymptomatic bacteriuria is very common. In healthy women, asymptomatic bacteriuria increases with age, from Escherichia coli is the most frequent organism isolated, but a wide variety of other organisms may occur. Bacteriuria may be transient or persist for a prolonged period. Pregnant women with asymptomatic bacteriuria identified in early pregnancy and who are untreated have a risk of pyelonephritis later in pregnancy of 20% to 30%. Bacteremia is frequent in bacteriuric subjects following mucosal trauma with bleeding, with 5% to 10% of patients developing severe sepsis or septic shock. These two groups with clear evidence of negative outcomes should be screened for bacteriuria and appropriately treated. Asymptomatic bacteriuria in other populations is benign and screening and treatment are not indicated. Antimicrobial treatment has no benefits but is associated with negative outcomes including reinfection with antimicrobial resistant organisms and a short-term increased frequency of symptomatic infection post-treatment. The observation of increased symptomatic infection post-treatment, however, has led to active investigation of bacterial interference as a strategy to prevent symptomatic episodes in selected high risk patients.
- 1 March 2014
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 28 (1) , 91-104
Urinary Tract Infections in Special Populations
- 1 March 2014
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 28 (1) , 91-104
Urinary Tract Infections in Special Populations
- Open Access
- 12 February 2014
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 3 (1) , 6
Antimicrobial stewardship in long term care facilities: what is effective?
Intense antimicrobial use in long term care facilities promotes the emergence and persistence of antimicrobial resistant organisms and leads to adverse effects such as C. difficile colitis. Guidelines recommend development of antimicrobial stewardship programs for these facilities to promote optimal antimicrobial use. However, the effectiveness of these programs or the contribution of any specific program component is not known. For this review, publications describing evaluation of antimicrobial stewardship programs for long term care facilities were identified through a systematic literature search. Interventions included education, guidelines development, feedback to practitioners, and infectious disease consultation. The studies reviewed varied in types of facilities, interventions used, implementation, and evaluation. Comprehensive programs addressing all infections were reported to have improved antimicrobial use for at least some outcomes. Targeted programs for treatment of pneumonia were minimally effective, and only for indicators of uncertain relevance for stewardship. Programs focusing on specific aspects of treatment of urinary infection – limiting treatment of asymptomatic bacteriuria or prophylaxis of urinary infection – were reported to be effective. There were no reports of cost-effectiveness, and the sustainability of most of the programs is unclear. There is a need for further evaluation to characterize effective antimicrobial stewardship for long term care facilities.
- 12 February 2014
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 3 (1) , 6
Open AccessAntimicrobial stewardship in long term care facilities: what is effective?
Intense antimicrobial use in long term care facilities promotes the emergence and persistence of antimicrobial resistant organisms and leads to adverse effects such as C. difficile colitis. Guidelines recommend development of antimicrobial stewardship programs for these facilities to promote optimal antimicrobial use. However, the effectiveness of these programs or the contribution of any specific program component is not known. For this review, publications describing evaluation of antimicrobial stewardship programs for long term care facilities were identified through a systematic literature search. Interventions included education, guidelines development, feedback to practitioners, and infectious disease consultation. The studies reviewed varied in types of facilities, interventions used, implementation, and evaluation. Comprehensive programs addressing all infections were reported to have improved antimicrobial use for at least some outcomes. Targeted programs for treatment of pneumonia were minimally effective, and only for indicators of uncertain relevance for stewardship. Programs focusing on specific aspects of treatment of urinary infection – limiting treatment of asymptomatic bacteriuria or prophylaxis of urinary infection – were reported to be effective. There were no reports of cost-effectiveness, and the sustainability of most of the programs is unclear. There is a need for further evaluation to characterize effective antimicrobial stewardship for long term care facilities.
- 21 January 2014
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 16 (1) , 1-7
Urinary Tract Infections in Patients with Spinal Injuries
Urinary tract infection remains an important problem for patients with spinal cord injury. Interventions used to promote bladder emptying and maintain low-pressure voiding have variable risks for urinary tract infection. Asymptomatic bacteriuria is common in this population and should not be treated. However, identification of symptomatic infection is compromised by difficulties in ascertainment of symptoms. Use of hydrophilic coated catheters for intermittent catheterization does not influence the frequency of symptomatic urinary tract infection. Botulinum toxin injection in the detrusor muscle or the urethral sphincter improves bladder emptying and does not influence the frequency of urinary infection. Asymptomatic bacteriuria is a common finding in pregnant women with spinal cord injury, but optimal management is not clear. Other research needs include further development and evaluation of interventions to decrease the frequency of infection, improve diagnostic precision, and limit the emergence of resistant organisms.
- 21 January 2014
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 16 (1) , 1-7
Urinary Tract Infections in Patients with Spinal Injuries
Urinary tract infection remains an important problem for patients with spinal cord injury. Interventions used to promote bladder emptying and maintain low-pressure voiding have variable risks for urinary tract infection. Asymptomatic bacteriuria is common in this population and should not be treated. However, identification of symptomatic infection is compromised by difficulties in ascertainment of symptoms. Use of hydrophilic coated catheters for intermittent catheterization does not influence the frequency of symptomatic urinary tract infection. Botulinum toxin injection in the detrusor muscle or the urethral sphincter improves bladder emptying and does not influence the frequency of urinary infection. Asymptomatic bacteriuria is a common finding in pregnant women with spinal cord injury, but optimal management is not clear. Other research needs include further development and evaluation of interventions to decrease the frequency of infection, improve diagnostic precision, and limit the emergence of resistant organisms.